These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 10566800

  • 1. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K, Lucken R, van de Moer A, Houghton S, Simpson B, Cameron A, Monkton P, Hennesy K, Ellis C.
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [Abstract] [Full Text] [Related]

  • 2. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ, Clough NE.
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [Abstract] [Full Text] [Related]

  • 3. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K, Borrmann E, Werner E.
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [Abstract] [Full Text] [Related]

  • 4. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004 Apr; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 5. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E, Schulze F, Cussler K, Hänel I, Diller R.
    Vet Microbiol; 2006 Apr 16; 114(1-2):41-50. PubMed ID: 16361070
    [Abstract] [Full Text] [Related]

  • 6. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R, Daas A, Behr-Gross ME.
    Dev Biol (Basel); 2002 Apr 16; 111():171-80. PubMed ID: 12678238
    [Abstract] [Full Text] [Related]

  • 7. [Development of in vitro methods for the potency testing of clostridial vaccines].
    Borrmann E, Schulze F, Diller R.
    ALTEX; 2001 Apr 16; 18(1):34-6. PubMed ID: 11248848
    [Abstract] [Full Text] [Related]

  • 8. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E.
    Dtsch Tierarztl Wochenschr; 2002 Apr 16; 109(4):178-82. PubMed ID: 11998370
    [Abstract] [Full Text] [Related]

  • 9. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF.
    Dev Biol Stand; 1976 Apr 16; 32():167-72. PubMed ID: 1001830
    [Abstract] [Full Text] [Related]

  • 10. Testing of veterinary clostridial vaccines: from mouse to microtitre plate.
    Redhead K, Wood K, Jackson K.
    Dev Biol (Basel); 2012 Apr 16; 134():45-50. PubMed ID: 22888594
    [Abstract] [Full Text] [Related]

  • 11. Prospects for the refinement and reduction of animal usage in the potency testing of Cl. chauvoei vaccines.
    Tilleray JH, Knight PA.
    Dev Biol Stand; 1986 Apr 16; 64():111-8. PubMed ID: 3792641
    [Abstract] [Full Text] [Related]

  • 12. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M.
    ALTEX; 2001 Apr 16; 18 Suppl 1():13-47. PubMed ID: 11854853
    [Abstract] [Full Text] [Related]

  • 13. An international survey of clostridial sera and vaccines.
    Davidson I.
    Dev Biol Stand; 1976 Apr 16; 32():3-14. PubMed ID: 187508
    [Abstract] [Full Text] [Related]

  • 14. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K, Rosskopf-Streicher U, Volkers P, Milne C.
    Pharmeuropa Spec Issue Biol; 2001 Aug 16; 2001(1):75-88. PubMed ID: 11705102
    [Abstract] [Full Text] [Related]

  • 15. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U, Johannes S, Gyra H, Beckmann R, Cussler K.
    Dev Biol (Basel); 2002 Aug 16; 111():153-8. PubMed ID: 12678235
    [Abstract] [Full Text] [Related]

  • 16. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens.
    Crichton R, Solomon J, Barton AM.
    Biologicals; 1990 Jan 16; 18(1):49-54. PubMed ID: 2317354
    [Abstract] [Full Text] [Related]

  • 17. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD.
    Dev Biol Stand; 1996 Jan 16; 86():73-6. PubMed ID: 8785994
    [Abstract] [Full Text] [Related]

  • 18. Clostridium oedematiens: observations on potency assaying.
    Macheak ME.
    Dev Biol Stand; 1976 Jan 16; 32():103-12. PubMed ID: 1001824
    [Abstract] [Full Text] [Related]

  • 19. Field studies in sheep with multicomponent clostridial vaccines.
    Kerry JB, Craig GR.
    Vet Rec; 1979 Dec 15; 105(24):551-4. PubMed ID: 532068
    [Abstract] [Full Text] [Related]

  • 20. Some problems concerning the assay of Clostridium chauvoei vaccine in laboratory animals.
    Knight PA, Kent J.
    Dev Biol Stand; 1976 Dec 15; 32():143-50. PubMed ID: 1001828
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.